Takeda Pharmaceutical
337 hedge funds and large institutions have $2.53B invested in Takeda Pharmaceutical in 2019 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 86 increasing their positions, 104 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
337
Holders Change
+21
Holders Change %
+6.65%
% of All Funds
6.65%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.12%
New
64
Increased
86
Reduced
104
Closed
38
Calls
$95.2M
Puts
$92.8M
Net Calls
+$2.39M
Net Calls Change
+$5.4M
Top Buyers
| 1 |
GCM
Glenview Capital Management
New York
|
+$61.9M |
| 2 |
RA
Rovida Advisors
Fort Lauderdale,
Florida
|
+$22.8M |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$6.73M |
| 4 |
Millennium Management
New York
|
+$6.65M |
| 5 |
Renaissance Technologies
New York
|
+$5.99M |
Top Sellers
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$162M |
| 2 |
HI
HBK Investments
Dallas,
Texas
|
-$45.4M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$36.9M |
| 4 |
D.E. Shaw & Co
New York
|
-$28.9M |
| 5 |
SGA
Sector Gamma AS
Oslo,
Norway
|
-$15.5M |
